Modeling of celiac disease immune response and the therapeutic effect of potential drugs - Wikidata - wikimedia - TriplyDB

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

http://www.wikidata.org/entity/Q34798574

about

The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate Immunopathogenesis and therapeutic approaches in pediatric celiac disease.New Technologies in the Processing of Functional and Nutraceutical Cereals and Extruded Products

P2860

Q26771888-E0F9CE5D-FC04-4A99-A9AE-A247C1DF33AC Q38783192-EC97580E-1704-486F-B1CD-10AEA53563C8 Q57594745-82331E9A-488B-4D91-BD51-46EAFA938F56

P2860

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

http://www.wikidata.org/entity/Q34798574

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@ast

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@en

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@nl

type

label

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@ast

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@en

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@nl

prefLabel

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@ast

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@en

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@nl

P1433

Q34798574-1BCAACB1-9BC5-4E2B-ABFC-D90E319C911C

P1476

Q34798574-909777FE-5D87-41D0-813E-6AF3F77D3222

P2093

Q34798574-0EFC6DA5-BF85-4C00-8A2F-FCE918B242B1

Q34798574-23C47FFB-E2BA-44CA-9D34-84DBC193BF13

Q34798574-251D764C-CC71-41DE-9D7A-E3F8DD910E0A

Q34798574-7B2A3192-BF0C-47B9-9886-596B2EE1DB71

Q34798574-86001702-C8A6-408B-9CC6-FF8BB52CA7AF

Q34798574-AC0F744D-0A7C-4563-8134-68C2CB604CCC

Q34798574-B617E343-61B5-4336-B0D1-F00F90060F2A

Q34798574-E21AC219-94B7-4C1B-8D2E-718C5514C60E

P2860

Q34798574-03EE016C-AFC4-41A1-8145-56CBFA14717E

Q34798574-0AF1F9C2-4E8B-4BA6-87CD-CE16961FFAC5

Q34798574-110574CD-56F2-44EF-9523-DF185A795D2F

Q34798574-1DAFDAC5-D197-408D-8345-A634EE158EA1

Q34798574-24209066-FDB8-42F5-9C4B-C7E9DFA333C8

Q34798574-3382AC09-E8E8-4DC4-AA40-4477F343F548

Q34798574-349735C7-0BD5-4E24-9D24-708B7B0370E3

Q34798574-36B814CF-91DE-4C9D-8238-345915E29122

Q34798574-3A0DF972-9183-44F4-866F-3F918DE9E3D5

Q34798574-3CCCC84E-B27E-472F-9014-B09BAA3A1DF1

P2888

Q34798574-A1155C6E-7426-4F2B-9B28-711EF0F40D52

P304

Q34798574-A45359B7-4201-4E00-B83B-AD844A474EA1

P31

Q34798574-1F05D71C-48A7-406F-8A9D-BF0C13EF5975

P356

Q34798574-491A39CA-5FC1-4511-8AB6-517BFC41C82F

P478

Q34798574-17D6C5BE-B536-46C8-93A3-95CA0FE81187

P577

Q34798574-23F83106-D926-4C30-B802-D5A139A0DA3B

P5875

Q34798574-7A81AFE6-9C64-4382-83E8-A037A6FDED8B

P6179

Q34798574-DCE961D8-BE10-4B18-A595-14ED6795E17A

P698

Q34798574-10B5A089-93BF-48F0-AE23-6F5BA594186F

P932

Q34798574-23279A0E-AADD-4651-8DF3-EF876DDD07DF

P356

P1433

BMC Systems Biology

P1476

Modeling of celiac disease immune response and the therapeutic effect of potential drugs

@en

P2093

Cesar Pichardo-Almarza

http://www.w3.org/2001/XMLSchema#string

Lourdes Cucurull-Sanchez

http://www.w3.org/2001/XMLSchema#string

M Victoria Flores

http://www.w3.org/2001/XMLSchema#string

Neil Benson

http://www.w3.org/2001/XMLSchema#string

Oleg O Demin

http://www.w3.org/2001/XMLSchema#string

Oleg V Demin

http://www.w3.org/2001/XMLSchema#string

Sergey V Smirnov

http://www.w3.org/2001/XMLSchema#string

Victor V Sokolov

http://www.w3.org/2001/XMLSchema#string

P2860

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3

IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production

Transepithelial transport and enzymatic detoxification of gluten in gluten-sensitive rhesus macaques

Structural basis for gluten intolerance in celiac sprue

DBSolve Optimum: a software package for kinetic modeling which allows dynamic visualization of simulation results

Monocytes differentiated with IL-15 support Th17 and Th1 responses to wheat gliadin: implications for celiac disease.

Current concepts of celiac disease pathogenesis.

HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease

Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.

P2888

P304

56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1752-0509-7-56

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245537129

http://www.w3.org/2001/XMLSchema#string

P6179

1036492218

http://www.w3.org/2001/XMLSchema#string

P698

23826972

http://www.w3.org/2001/XMLSchema#string

P932

3706242

http://www.w3.org/2001/XMLSchema#string